Bringing relief to rheumatoid arthritis patients through biosimilars

Bringing relief to rheumatoid arthritis patients through biosimilars

Society data shows that six million Canadians have arthritis, and that means one in five Canadians lives with arthritis – and the pain and joint damage that often go along with it can be debilitating and lessen the ability to take care of daily tasks of living.

News story posted on 2021-11-02T00:00:00.0000000Z